Acme Formulation Private Limited - Company Profile

It is a pharma private limited company based in Himachal Pradesh, Himachal Pradesh, India, established in 2004.
2004 Himachal Pradesh, Himachal Pradesh, India Active
Last Updated:
Access Report
About Acme Formulation Private Limited

Acme Formulation Private Limited, a active private limited company, was established on 21 June 2004 in Himachal Pradesh, Himachal Pradesh, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24230HP2004PTC027223. Registered under ROC Roc Himachal Pradesh. it is unlisted. It has an authorized capital of ₹18.00 Cr and a paid-up capital of ₹10.25 Cr.

It upholds a compliant status. Employing 601 professional, Its leadership includes Vikas Sharma (Whole-Time Director), Aswin Vikram (Director), Nikhilkumar Srivastava (Director). Past directors included Dilipkumar Shah Bhogilal, Lincoln Lin Feng Pan, Vikas Sharma. It holds ₹115.72 Cr open charges and ₹202.58 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Village Chowkiwalatehsil Nalagarh Distt Solan, Himachal Pradesh, Himachal Pradesh.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24230HP2004PTC027223

  • Registration Number

    027223

  • Incorporation Date

    21 June 2004

  • Authorized Capital

    ₹18.00 Cr

  • Paid-Up Capital

    ₹10.25 Cr

  • ROC Code

    Roc Himachal Pradesh

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 18.00 Cr
  • Paid Up Capital ₹ 10.25 Cr
  • Company Age 21 Year, 7 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 115.72 Cr
  • Satisfied Charges ₹ 202.58 Cr
  • Revenue Growth **** 26.02%
  • Profit Growth **** 146.38%
  • Ebitda **** 79.09%
  • Net Worth 5.58%
  • Total Assets **** 2.98%
Company report

Acme Formulation Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Acme Formulation Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Acme Formulation Private Limited?
Current Directors
Name Designation Appointment Date Status
Vikas Sharma Whole-Time Director 29 Jul 2020 Current
Aswin Vikram Director 04 Oct 2021 Current
Nikhilkumar Srivastava Director 04 Oct 2021 Current
Viral Shah Managing Director 24 Jan 2007 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 18 Oct 2012 Past
Pramod Abcsdd Director 17 Jun 2022 Past
Pramod Abcsdd Additional Director 29 Jul 2020 Past
Pramod Abcsdd Director 01 Jul 2010 Past
Pramod Abcsdd Company Secretary - Past
Pramod Abcsdd Whole-Time Director 29 Sep 2010 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Acme Formulation.

Acme Formulation Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 26.02% increase. The company also saw a substantial improvement in profitability, with a 146.38% increase in profit. The company's net worth moved up by a moderate rise of 5.58%.

Acme Formulation revenue growth over time
Acme Formulation profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 26.02%
*******
*******
*******
*******
Revenue from Operations
*******
 23.04%
*******
*******
*******
*******
Total Assets
*******
 2.98%
*******
*******
*******
*******
Profit or Loss
*******
 146.38%
*******
*******
*******
*******
Net Worth
*******
 5.58%
*******
*******
*******
*******
EBITDA
*******
 79.09%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Acme Formulation?

In 2023, Acme Formulation had a promoter holding of 40.66% and a public holding of 59.34%. The company had 4 Subsidiaries. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹1,157,200,000.00

Satisfied Charges

₹2,025,800,000.00

Charges Breakdown by Lending Institutions
  • Hdfc Bank Limited : 65.00 Cr
  • State Bank Of India : 50.72 Cr
Latest Charge Details
Date Lender Amount Status
06 Aug 2021 State Bank Of India ₹50.72 Cr Open
17 Jan 2020 Hdfc Bank Limited ₹30.50 Cr Open
17 Jan 2020 Hdfc Bank Limited ₹8.50 Cr Open
17 Jan 2020 Hdfc Bank Limited ₹26.00 Cr Open
23 Nov 2016 Hdfc Bank Limited ₹25.50 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Acme Formulation?

Acme Formulation has a workforce of 601 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Acme Formulation, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Acme Formulation's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Acme Formulation
Recent Activity within the Organization
  • Director Appointment

    The activity Ginny Uppal was appointed as a Company Secretary was appointed as a Company Secretary on 15 Oct 2024 & has been associated with this company since 1 year 3 months . was completed.

  • Annual General Meeting

    Acme Formulation Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    The activity Acme Formulation Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Himachal Pradesh. was completed.

  • Charges

    The activity A charge with State Bank Of India of Rs. 50.72 Cr registered on 06 Aug 2021 with Charge ID 100484075 was modified on 30 Jun 2023. was completed.

  • Charges

    The activity A charge registered on 04 Jun 2007 via Charge ID 10053933 with General Manager District Industries Centre was fully satisfied on 26 Aug 2022. was completed.

  • Charges

    A charge registered on 31 Mar 2015 via Charge ID 10565258 with State Bank Of India was fully satisfied on 26 May 2022. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Acme Formulation Private Limited?

The CIN of Acme Formulation Private Limited is U24230HP2004PTC027223.

Where is Acme Formulation Private Limited headquartered?

Acme Formulation Private Limited is headquartered at Village Chowkiwalatehsil Nalagarh Distt Solan, Himachal Pradesh, Himachal Pradesh.

When was Acme Formulation Private Limited incorporated?

Acme Formulation Private Limited was incorporated on 21 June 2004.

Who are the current directors of Acme Formulation Private Limited?

The current directors of Acme Formulation Private Limited are

What is the primary industry of Acme Formulation Private Limited?

The primary industry of Acme Formulation Private Limited is Manufacturing.

Is Acme Formulation Private Limited a listed company?

Acme Formulation Private Limited is unlisted.

What is the capital structure of Acme Formulation Private Limited?

The authorized capital of Acme Formulation Private Limited is ₹18.00 Cr, and the paid-up capital is ₹10.25 Cr.

What is the compliance status of Acme Formulation Private Limited?

The compliance status of Acme Formulation Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available